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Abstract 17 
Background: Access to rehabilitation to prevent disability and optimise function is 18 
recommended for patients with cancer, including following diagnosis. Models to integrate 19 
rehabilitation within oncology services as cancer treatment commences are required, but 20 
must be informed by those they are intended to support. We aimed to identify views of 21 
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patients, carers and clinicians to develop and refine a rehabilitation model to be tested in a 22 
feasibility trial for people newly diagnosed with lung cancer or mesothelioma. 23 
Methods: We conducted a focus group study with people affected by lung cancer or 24 
mesothelioma, their carers, and clinicians providing their care to identify priorities for 25 
rehabilitation in this period. We sought views on core intervention components, processes 26 
and outcomes, and integration with oncology services. Data were analysed using thematic 27 
analysis. 28 
Results: Fifteen clinicians (oncologists, nurse specialists, physiotherapists and occupational 29 
therapists), nine patients and five carers participated. A proposed outline rehabilitation 30 
model was perceived as highly relevant for this population. Participants recommended 31 
prompt and brief rehabilitation input, delivered whilst people attend for hospital 32 
appointments or at home to maximise accessibility and acceptability.  Participants 33 
recognized variation in need and all prioritised tailored support for symptom self-34 
management, daily activities and the involvement of carers. Clinicians also prioritised 35 
achieving fitness for oncology treatment. Patients and carers prioritised a sensitive manner 36 
of approach, positivity and giving hope for the future. Participant’s recommendations for 37 
outcome measurement related to confidence in usual daily activities, symptom control, and 38 
oncology treatment completion rates over objective measures of cardiorespiratory fitness.  39 
Conclusion: The importance of providing tailored rehabilitation around the time of diagnosis 40 
for people with lung cancer or mesothelioma was affirmed by all participants. The refined 41 
model of rehabilitation recommended for testing in a feasibility trial is flexible, tailored and 42 
short-term. It aims to support people to self-manage symptoms, tolerate cancer treatments 43 
and to remain active and independent in daily life. It is delivered alongside scheduled 44 
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hospital appointments or at home by an expert practitioner sensitive to the psycho-social 45 
sequelae that follow a diagnosis of thoracic cancer.  46 
 47 
Key Words 48 
Lung cancer, mesothelioma, focus groups, rehabilitation, qualitative, feasibility trial 49 
Background 50 
Rehabilitation following a diagnosis of cancer is recommended to help people retain their 51 
functional independence during and after oncology treatment, and to mitigate subsequent 52 
disability.[1] Rehabilitation is defined as “a process aimed at enabling people with disabilities 53 
to reach and maintain their optimal physical, sensory, intellectual, psychological and social 54 
functional levels… and providing disabled people with the tools they need to attain 55 
independence and self-determination” (World Health Organisation: 56 
www.who.int/topics/rehabilitation/en/). National and international cancer guidelines 57 
recommend it is offered from the point of diagnosis. Nonetheless, rehabilitation services are 58 
not always integrated into cancer services and there is a lack of data on the feasibility and 59 
acceptability of rehabilitation models, particularly in advanced cancer.[2] New models are 60 
needed as despite compelling evidence of need relating to the physical, psychological, social 61 
and functional consequences of diagnosis and treatment, [3-6] people with thoracic cancer 62 
may not be willing to access services.[7-10]. Rehabilitation trials in this population are 63 
predominantly exercise or symptom self-management based and have not directly addressed 64 
participation in daily life activities in the period following diagnosis when people are at risk of 65 
deconditioning.[11]  To begin to address this, based on the literature, we developed outline 66 
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parameters for a comprehensive model of rehabilitation. These included: integration with 67 
oncology services; delivery soon after diagnosis; and tailored components to support people 68 
maintain participation in daily activities and minimise the onset of impairments as they 69 
commence cancer treatment (see figure 1). To support identification of environmental and 70 
personal factors which may act as barriers to participation in rehabilitation,[9, 12, 13], 71 
determinants or mechanisms of effect[14]  the outline model was underpinned by the World 72 
Health Organisation International Classification of Function Disability and Health,[15] plus 73 
theories of rehabilitation[16] and behaviour change (see figure 1).[17-19]  74 
This outline model of rehabilitation meets the definition of complexity as defined in the 75 
Medical Research Council framework for the development and evaluation of complex 76 
interventions.[20] Thus, as part of the intervention modelling and development, we 77 
conducted this qualitative study to address key uncertainties relating to the model prior to 78 
testing it in a future randomised feasibility trial.[21] Recruiting patients to randomised 79 
controlled trials (RCTs) is challenging and prospective identification of issues relevant their 80 
successful conduct is recommended.[20] We therefore aimed to elicit patient, family and 81 
clinician views to further develop and refine the outline rehabilitation model. We also aimed 82 
to elicit factors that may facilitate or hinder participation in a feasibility trial of a rehabilitation 83 
intervention, including priorities for rehabilitation components and processes, trial outcomes 84 
valued by patients and clinicians, and potential mechanisms of action. We also sought 85 
preferences for the trial delivery, including how to align activities with usual oncology and/or 86 
palliative care services. 87 
Method. 88 
Design  89 
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This qualitative study sits within the development phase of an overarching sequential 90 
exploratory mixed-methods project. It is reported in accordance with the consolidated 91 
criteria for reporting qualitative research (COREQ) guidance[22] [see Additional file 1]. Focus 92 
groups were conducted with an action focused pragmatic design. This methodology 93 
provided an efficient, economical method for obtaining participants’ views on health 94 
services where individual phenomenological data were not required.[21, 23] The facilitated 95 
group discussions promoted interactions between participants, allowed researchers to 96 
interact and respond to participants’  comments and potentially revealed richer and clarified 97 
data compared to individual interviews or questionnaires.[24, 25] Being part of a group 98 
discussion may also have improved respondent’s willingness to share their views.[26]   99 
 100 
Participants and Setting 101 
Purposive sampling was used to obtain views from across two target groups; the first 102 
included those living with thoracic cancer (any primary lung cancer or pleural 103 
mesothelioma), informal carers, and members of Patient Support Organisations focusing on 104 
thoracic cancer; and the second included oncologists, chest physicians, lung cancer and 105 
palliative care clinical nurse specialists (CNS), allied health care professionals (AHPs), social 106 
workers, and psychologists with an interest in thoracic cancer. We aimed to recruit 12-15 107 
participants from each population group (30 in total). Given the focused nature of our study 108 
within this specified population, the communication skills of the focus group facilitators and 109 
the cross-sectional nature of our analysis plan, we considered that this sample size would 110 
provide sufficient ‘information power’[27] to meet the aims of the study within a pragmatic 111 
time frame. We expected to undertake three focus groups per population group due to the 112 
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logistical constraints experienced by clinicians and patients undergoing investigations and 113 
treatments. We did not intentionally seek data saturation.[28]  114 
Participants were invited to participate via public adverts, distributed via Patient Support 115 
Organisations, Cancer Information Centres, clinical special interest groups, and oncology 116 
and rehabilitation services in the sites (one site in the Midlands and two in the London 117 
region, UK) planned for the randomised feasibility trial. Participants had to be willing to 118 
travel to a study venue and join a group discussion in English (via interpreters if available) 119 
for approximately 90 minutes. Travel costs were reimbursed but no payment was provided 120 
for participation. Patients treated with radical surgery were excluded as the initial intended 121 
focus of the intervention was on patients on a non-curative treatment pathway, who 122 
represent the majority of people with thoracic cancer. 123 
Data Collection 124 
A systematic review[11] and discussions within the research team and a Patient and Public 125 
Involvement (PPI) forum informed the development of the topic guide (see Additional file 2). 126 
Prior to attendance, participants were sent and asked to consider four short written patient 127 
stories, based on the literature and the first author (JB’s) clinical experience as a palliative 128 
care physiotherapist. These featured patients with varied functional impairments and 129 
concerns, to highlight the range of need in people with lung cancer or mesothelioma. They 130 
were designed to inform and stimulate group discussion. Importantly, they provided a 131 
mechanism for participants to discuss hypothetical scenarios, as well as or instead of their 132 
own experience,[29, 30] to help us identify rehabilitation components and service processes 133 
needed to best support people manage symptoms and remain active and independent 134 




During each focus group, two researchers (JB and MM, BE, SP or MD) facilitated discussions 137 
on key components and strategies that should be included in the rehabilitation service, how 138 
the service should be delivered, including integration with other services, issues the research 139 
team need to consider when inviting people to join the trial that might influence their decision 140 
to participate and domains for trial outcomes. JB and MM are physiotherapists with 141 
experience supporting people with advanced cancer accessing palliative care services. JB, 142 
MM, BE, SP & MD have experience facilitating focus groups and interview studies in oncology 143 
and palliative care research. Field notes were taken to allow for cross-checking with audio-144 
recordings, but were not used directly in the analysis. All participants were given an 145 
opportunity to ask the researchers questions relating to the participant information sheet on 146 
arrival at the focus group, prior to written informed consent. The researchers had no prior 147 
relationship with patient or informal carer participants. Recruitment took place between 148 
January–September 2017 at three centres, two in London and one in Nottingham. We did not 149 
conduct member checking as extracting individual participant data from the group data alters 150 
the context of the utterances and may alter the meaning.[31]   151 
 152 
Data Analysis 153 
Group discussions were audio recorded, transcribed verbatim and analysed using thematic 154 
content analysis.[32] Initial themes with potential to refine components of the rehabilitation 155 
service, trial processes and outcomes were identified from a preliminary review of the 156 
transcripts (JB). Transcripts were then independently coded line-by-line by two researchers 157 
(JB, BE) and interpreted deductively to address the study aims with additional themes 158 
interpreted inductively.[31]  NVivo 11 software (QSR International) was used to incorporate 159 
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discussion content, different perspectives on a topic, and drawing together of themes. 160 
Summary data were analysed and refined following discussion (JB, BE, MM, IJH) to identify 161 
common and divergent issues. As we sought participants’ views to inform the core 162 
intervention components, implementation processes and valued outcomes for a future 163 
feasibility trial, sub themes were refined and final themes were organised under overarching 164 
categories described in the MRC Process Evaluation Guidance.[14, 33] We sought to develop 165 
our theories of change,[34]to improve our understanding of contextual factors and potential 166 
mechanisms of effect that may interact with the intervention and processes during the 167 
feasibility trial. These factors are presented within each section of the results.  168 
 169 
Results 170 
Fifty-two people (35 patients and informal carers, 17 clinicians) responded to the public 171 
advert. Two patient participants were members of patient support organisations. Reasons for 172 
non-participation included: 6 were unable to attend on scheduled date(s) 5 did not reply to 173 
contact following receipt of Participation Information Leaflet, 5 were unable to travel or not 174 
feeling well enough to attend; 4 were not interested and 3 were cured of disease and 175 
ineligible.  176 
Twenty-nine participants consented and took part in eight focus groups ranging from 43 to 177 
77 min. with a median of 60 min. Due to difficulties convening groups that all interested 178 
participants could attend, and to minimise the time that recruited patient participants had to 179 
wait to attend a group, four, rather than the planned three, focus groups were held with each 180 
population group.  15 clinicians (12 females/3 male, 2 oncologists, 4 physiotherapists, 3 181 
occupational therapists, 3 lung cancer nurse specialists and 1 palliative care nurse specialist) 182 
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with all the recruitment sites for the feasibility trial were represented. 9 patients and 5 183 
informal carers (9 female/5 male) participated.  Of the 9 patients, 6 had a diagnosis of lung 184 
cancer and 3 mesothelioma. One participant was about to commence first line treatment, 185 
one had completed treatment and seven were receiving maintenance chemotherapy or 186 
immunotherapy. 187 
We present participant views that have informed and refined the design of the 188 
rehabilitation model.[35, 36] Nine themes are organised under three MRC Process 189 
Evaluation categories: (i) Components of intervention; (ii) Implementation of trial and 190 
intervention and (iii) Outcomes. Factors relating to context and mechanisms of action are 191 
discussed within these three categories below and are presented separately in Figures 1 and 192 
2 that show the outline and refined rehabilitation model respectively.  193 
(i) Components of the rehabilitation intervention  194 
Divergence was observed between patient/carer and clinician respondent views regarding 195 
the purpose of rehabilitation. Patients and carers emphasised that their main concerns 196 
following diagnosis were to get on with ‘normal life’ and they discussed how rehabilitation 197 
could help them ‘keep going’. Clinicians supported these aims, but prioritised symptom 198 
management and physical activity as a means to support people to cope with oncology 199 
treatment, increase treatment options, and help patients complete a full treatment course 200 
and cope better with side effects. Despite this, responses from both groups confirmed that 201 
while the core components of the outline model (Figure 1) should be retained (supporting 202 
usual activities; tailored symptom management and physical activity ± exercise), refinements 203 
were needed to maximise its acceptability to patients in the contextual period following 204 
diagnosis. It was recommended that although individual participants may need varying 205 
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combinations of these components, an overarching educational and motivational approach 206 
were important components and potential mechanisms of action for everyone (see Figure 2). 207 
 208 
Supporting usual activities 209 
Patients and carers recommended that intervention components help people address the 210 
impact of diagnosis and the effects of treatment on their normal life, rather than as a means 211 
to complete oncology treatment. They described the devastation and shock of diagnosis that 212 
can be a major threat to usual roles and activities. Components should help them feel safe, 213 
and reduce concerns that they may do themselves harm. Even previously fit people may 214 
struggle to maintain normal routines and activities on hearing they have an illness they 215 
associate with death. 216 
 217 
 “…the other really important thing is to just keep your life... as normal as possible. I don’t 218 
know if a lot of people are managing that.” (PFG08 patient) 219 
“…some people, I know of several, when they were diagnosed, they just gave up completely. 220 
One guy just sat in the chair, you know, wanting to die. His wife was distraught, because he’d 221 
been a very active person, so everybody reacts differently to the diagnosis.” (PFG04 patient) 222 
This was also valued by clinicians who recognised such concerns exist and are not always 223 
addressed during clinic appointments, which focus on treatment planning.  224 
“They don't always tell us everything when they come into clinic. They're just focused on 225 
discussing about chemotherapy, not everything. I feel that a lot of them, they don't tell us. If 226 
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we provide extra support and services I think they might just come out and tell, "Oh, this is a 227 
problem I'm facing at home”13, line. (CFG11 oncologist) 228 
Tailored symptom management 229 
In considering the aims for rehabilitation, participants reported that symptom management 230 
components must be tailored as the impact of symptoms on individuals varies considerably. 231 
Responses demonstrated that physical and psychological symptoms may precede diagnosis 232 
and impact on all aspects of daily life. Some reported feeling well initially, only developing 233 
symptoms during oncology treatment. Others were initially symptomatic, but symptoms 234 
resolved quickly following the start of treatment. The diversity highlighted the need for a 235 
detailed functional assessment and a personalised approach to support individuals to 236 
maintain participation in their normal roles and routines. Although functional limitation is 237 
highly prevalent at diagnosis in thoracic cancer, it should not be assumed. 238 
 “My fatigue started before my diagnosis. It started off with a dry cough, which just lasted 239 
for months and it didn’t go away. I started, you know, getting more and more fatigued. I 240 
couldn’t walk for more than a few yards without stopping for breath”. (PFG05 patient) 241 
I couldn’t walk the kids to school, I couldn’t even walk to the end of the road really. Even 242 
walking upstairs was… you know and having breathing problems, you do panic sometimes. 243 
You can’t get your breath and it is trying to calm yourself down, especially if the kids are in 244 
the room and you don’t want to scare them.” (PFG12 patient) 245 
Management strategies should meet immediate needs when symptoms are present, but be 246 
offered alongside as a preventative approach. Patients, clinicians and carers agreed it was 247 
important to offer advice and training in anticipation of common experienced symptoms, as 248 
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this may decelerate the impact of the disease, improve coping, and reduce distress. This 249 
preventative approach was considered particularly important for people who either do not 250 
have symptoms, or where symptoms have responded to treatment but may reoccur.  251 
Strategies discussed included advice and support for ongoing daily activity, general physical 252 
activity, exercise and dietary advice. Participants highlighted the physical symptoms of 253 
weakness, fatigue, breathlessness, weight loss, cough and pain, but also recommended that 254 
components address the psychological symptoms such as depression, anxiety and worries 255 
for the future. 256 
 “I think when you’re first diagnosed with cancer, all these symptoms that you’ve all talked 257 
about, if it’s not been explained to you that these are the feelings. But you see somebody like 258 
a physiotherapist or whatever, that can explain this to you and show you exercises that you 259 
can do at home to make you feel better, to make you feel you’re achieving something.” 260 
(PFG09 patient) 261 
I've found that anxiety is quite high in a lot of those patients. Depression can be quite a 262 
prevalent symptom as well, but I think anxiety is the biggest, probably one of the biggest 263 
things you see at that stage. It impacts upon everything they do, simple things. They 264 
sometimes can't do the simplest things because they're worrying about what's going to 265 
happen. (CFG08 AHP) 266 
Optimising physical fitness 267 
Participants recommended that rehabilitation should explicitly raise the importance of 268 
physical fitness and activity to help people cope with symptoms and treatment. Although 269 
this needs to be tailored, respondents considered it important to offer this to all patients, 270 
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not just those with higher levels of fitness pre-diagnosis. Reflecting on their own 271 
experiences, patient participants thought that the language of fitness may foster hope at a 272 
time when much of the news being received is distressing, and may therefore improve the 273 
acceptability of the service. 274 
Divergence on the role of fitness components was observed between clinicians and patient 275 
or informal carer participants. Clinicians emphasised the importance of optimising physical 276 
fitness for treatment, and that improving it could expand options and increases completion 277 
rates.  278 
“‘You’ve been given this diagnosis. We want to support you, so that you are well enough and 279 
as fit as you can be to go through whatever treatment they offer you, whatever that may 280 
be,’ would be a good first step, because it would also maybe take their mind a little bit off 281 
the diagnosis and allow them to see the bigger picture.” (CFG12 oncologist)  282 
In contrast, patients and carers had not considered that participation may improve 283 
treatment outcomes. They recognised value in terms of promoting participation in everyday 284 
activities and tasks, and carrying on with interests; indeed those who had exercised were 285 
able to recall functional benefit. They recognised some people may find it hard to think 286 
about fitness at diagnosis, and small changes in behaviour, e.g. avoiding unnecessary rest, 287 
may be more achievable. 288 
“It helps boost your whole system. You’re going to be less tired if you’re more active because 289 
the more you sit back and lay down, then you’re just going to get much weaker.” (PFG10) 290 
A motivational approach 291 
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Patients and carers raised the importance of the attitude and behaviour of the health care 292 
professional delivering the service. As well as having insight and expertise to support people 293 
in distress, they need skills to encourage reluctant or poorly-motivated people to participate. 294 
Family were also recognised as providing motivational support and participants 295 
recommended that trial participants are offered to invite a family member to be present 296 
during the intervention.  297 
“You’ve got to tell me and you’ve got to keep prodding and getting me there. I might say, “I 298 
don’t want you, I don’t want you,” but I do. I realise I do.” (PFG06 patient) 299 
 “It is so easy just to sit there, go off to your treatments, come back home, sit there and 300 
[spouse] really encouraged me… “Why don’t you get up and do something, get everything 301 
working again.” I think I needed that push really, in the right direction.” (PFG12 patient) 302 
Participants described that beliefs about cancer and its treatment cause some patients and 303 
their families to lose confidence to be active. They potentially limit themselves, even in 304 
situations where they may respond well to treatment and have months, if not years, to live. 305 
Participants recommended that professionals should recognise and sensitively address these 306 
beliefs to maximise engagement with the intervention components. 307 
“one lady who, after her diagnosis, went home, wrote a will, gave up her job, started preparing 308 
for end of life, when actually two years down the line she’s still here with us.” (CFG03 CNS) 309 
 310 
All participants recognised that some individuals need more encouragement than others to 311 
participate, and that some would not be interested in rehabilitation. 312 
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 “I think if you are in a palliative situation, it feels as if there’s more to take in, and there’s 313 
the, “Well, why bother?” kind of attitude, quite often, and overcoming that takes a bit of 314 
time.” (CFG12 oncologist) 315 
Participants also described that multiple hospital and treatment appointments may influence 316 
how much time people felt they could give to participating in rehabilitation. They considered 317 
that self-management strategies are more likely to be used if they target meaningful priorities 318 
or goals and can be flexibly tailored to fluctuating health states. 319 
“I have to be in the hospital all the time. I can’t go to work and I’m self-employed, do you 320 
understand? So all those things are changing. You lose everything in your head…You actually 321 
lose your confidence. (PFG11 patient) 322 
Promoting participants motivation and self-confidence was considered important but 323 
strategies should be realistic in their scope. Some patients demonstrated resilience and were 324 
using self-directed strategies to manage symptoms and maintain fitness. In these situations, 325 
simple practical advice or affirmation of their own strategies may be all that is needed from a 326 
rehabilitation service. 327 
“…gentle exercise to keep you going and then maybe have another visit from physio or 328 
whatever and say, ‘Right, I’ve achieved this, I’ve done my 10,000 steps or whatever it is a 329 
day.’ They say, ‘Right, that’s brilliant. So let’s up it then to 20,000 steps or try doing this....’ 330 
Encouraging them but pointing out... what you can do, what’s available for you to do to keep 331 
you fit.” (PFG09 patient) 332 
 333 
(ii) Trial and intervention implementation 334 
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Trial screening and recruitment 335 
When considering inviting people to join the feasibility trial, participants described that timing 336 
and manner of approach as important to consider. As described above, initial responses to 337 
diagnosis may be dominated by feelings of shock, distress and thoughts of death. It was 338 
agreed by all participants that usually, it would not be appropriate to introduce the trial on 339 
the day patients receive their diagnosis, when they may be overwhelmed trying to absorb 340 
large amounts of information and make decisions about treatment. Soon after this 341 
appointment was preferred, with timing tailored to individual context. For those receiving 342 
their diagnosis as an outpatient, the subsequent appointment was preferred. Participants 343 
could see the advantages of waiting until treatment was planned. However, as the waiting 344 
period between diagnosis and treatment can be prolonged (several weeks), some patients 345 
may gain benefit from receiving rehabilitation before oncology treatment commences. 346 
Participants felt that screening contact and recruitment contacts could be made sooner if 347 
participants were diagnosed during an in-patient admission.   348 
 349 
 “…if it can improve your fitness during that period they might cope with the chemotherapy 350 
better. Patients are sitting at home thinking, ‘I haven't started any treatment’. They're 351 
worried. They always keep on thinking that they haven't started anything.” (CFG11 oncologist) 352 
“I’m not absolutely sure that the first time that you attend for a consultant appointment, when 353 
you’ve got all other things on your mind, that that is necessarily the best time to be asked 354 
whether you want to join in all these things. You can’t put it into a context.” (PFG02 carer) 355 
Linked closely to timing, the manner of approach was paramount for patients and their 356 
families. Some reported that initially they could only think about telling family members or 357 
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getting things in order at home and preparing for death and may not have perceived the 358 
relevance of rehabilitation. They wanted those involved in screening and recruitment to 359 
present information about the service and the trial sensitively, demonstrating understanding 360 
about each persons’ situation and discussing the trial in relation to how it might help them in 361 
their situation. Clinicians felt it was important to promote that the intervention as helping 362 
people get fit for treatment. 363 
 “Like [other participant] mentioned earlier, it’s about the manner. There should be a certain 364 
way to sit down with people and explain to them, because you’ve already given them really, 365 
really bad news. So if you could also explain to them in an educational way so that you don’t 366 
make them feel anymore worse than they already do. That will be quite helpful.” (PFG10 carer)  367 
 “I think after a decision has been made what treatment they want to go for, then having 368 
another session saying, ‘Okay, you’ve decided to go for that treatment. Let’s get you as well 369 
as you can, so that you can go through that treatment and maintain your independence.” 370 
(CFG12 Oncologist) 371 
Participants reported patients may feel overwhelmed with information at diagnosis that is 372 
hard to absorb, especially written information which may get put away, unread.  They 373 
recommended that information about the trial be paced, and tailored to each person’s 374 
readiness to engage.  Some patients and carers reported that they did not understand the 375 
need for the rehabilitation model to be trialled in a controlled manner, and that they would 376 
not have wanted to be allocated to care as usual. Others recognised that a trial may ascertain 377 
if the rehabilitation offers additional benefit to oncology treatment. On discussion, they 378 
recommended that a clear explanation of the reasons for randomisation should be provided 379 
in all trial information. 380 
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 “It’s going to work anyway. It’s obvious, if someone is lying in bed ill and then someone is 381 
getting up and doing exercise, they’re going to benefit from it. I don’t think you need to trial 382 
it. (PFG06) “I’m with you there…yes.” (PFG08)] 383 
Despite the challenges in making the initial approach to potential participants, clinicians, 384 
patients and carers considered that the patients should be offered participation in the trial in 385 
the period following diagnosis, rather than waiting for first oncology treatments to be 386 
completed. Clinicians highlighted the value of delivering early rehabilitation to optimise 387 
fitness and well-being. They suggested tailoring information about the trial to individuals’ 388 
current health status. For those without functional needs, the trial could be presented as 389 
testing an intervention that aims to get people fit for treatment. For those who are unwell, 390 
the trial could be presented as testing an intervention to help people manage the symptoms 391 
and limitations.  392 
With the benefit of hindsight, patients described how the changes in their health status 393 
between diagnosis and treatment may have impacted on their engagement with a trial. Some 394 
felt well at diagnosis and did not anticipate how they would feel once treatment started, 395 
reported they may have declined to participate later on. Those whose health condition was 396 
deteriorating rapidly at diagnosis reported that whilst they may have declined to participate 397 
in a strenuous exercise intervention, they were open to an intervention to meet their 398 
immediate needs or feel more positive about their future.  399 
“I think you would have struggled to listen to someone telling you to be active at that stage. 400 
You just couldn’t could you”? (PFG013 carer) “But the information I did get I think was really 401 
good from the guy.” (PFG012 patient) “Oh, the breathing and that, yes.” (PFG013 carer) 402 
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We had planned to include only patients with inoperable disease. However, clinical 403 
participants reported that patients having surgery would also benefit from this type of 404 
rehabilitation model. They recommended an inclusive eligibility criterion that includes 405 
patients on any oncology or palliative care treatment pathway.  406 
 “Then the people after surgery might struggle as well. I can't understand why one group is in, 407 
it all and not the other, the one on chemo-radiotherapy.  “I think … involve everybody.” 408 
(CFG11) “Absolutely do, yes.” (CFG09 CNS) 409 
Intervention delivery  410 
The strongest message to come from all participants was for a flexible rehabilitation service, 411 
integrated with scheduled hospital and oncology treatment appointments. This requires the 412 
model to be tailored around participants’ schedules, their health state and preferences.  413 
Necessities, such as the need to continue working or look after family, require some 414 
patients to continue with usual roles and responsibilities. Clinicians reported an increase in 415 
‘never smoked’ working adults, some caring for children. Three of the patient participants 416 
were caring for school age children. A flexible approach to service delivery may improve 417 
accessibility for patients with family commitments.  418 
“I kind of didn’t change my routine. I mean I’ve got three small children… You don’t know what 419 
to think, but I went into action. I thought I’m not going to let this conquer me. I’m stronger 420 
than this. I’m going to fight this.” (PFG08 patient) 421 
To maximise inclusivity, the rehabilitation should be offered to participants in the location of 422 
their preference, which may be hospital, at a schedule appointment, or in their own home. 423 
Participants and clinicians spoke of the boredom experienced by patients attending multiple 424 
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appointments, waiting for hours in clinic or on treatment. Participants would prefer to receive 425 
the rehabilitation during these waiting times than come back for additional appointments. 426 
For others, travel itself was burdensome due to distance or overall health, and in these 427 
circumstances home was the preferred location. Additionally, some patients and carers felt 428 
they would find it easier to learn rehabilitation techniques in their home environment. They 429 
considered that this flexibility would maximise participants’ willingness to join and remain on 430 
trial. 431 
“I would say the vast majority of patients voice to us that they don’t want to come up any 432 
extra. I don’t think you will get them turning up unless it is on a day that they have already got 433 
an appointment. That is a big one.” (CGF06 AHP) 434 
“…if someone was to approach you when you’re sitting there waiting for that oncologist. Is 435 
hours we’ve sat in waiting rooms. (PFG06 patient) “It’s tiring as well, so if you’re kept busy 436 
then it’s not going to be that bad.” (PFG10 carer) 437 
Clinicians felt that the proposed three contacts was appropriate and this was sufficient to 438 
address peoples’ functional needs following diagnosis without adding additional undue 439 
burden. Patients and carers were more concerned with not returning to the hospital for 440 
extra appointments than the number of contacts received during the intervention. 441 
However, they reported that some patients may want more prolonged involvement with 442 
rehabilitation services. Patient participants were happy with the proposed plan for referral 443 
to ongoing services, but were unsure about where or what these may be. Clinicians were 444 
also concerned about the availability of services for onward referral.  445 
(iii) Outcomes  446 
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Patient centred  447 
All participants recognised the challenges of measuring the impact of the service where the 448 
natural course of the disease and overall health state in participants will be varied and 449 
unpredictable. Consequently, objective measures of fitness were not considered useful in 450 
such a broad target population. 451 
“…it is so hard because of the population group. That is the thing because, you know, they just 452 
fluctuate so much, so getting any standardised assessment unless you are measuring 453 
something like their confidence in doing a task.” (CFG06 AHP) 454 
 455 
Instead, participants recommended patient reported outcome measures that assess changes 456 
in levels of symptom distress, physical activity and function alongside confidence to perform 457 
daily activities and to manage symptoms. Clinicians also recommended using a quality of life 458 
measure.  459 
 460 
 “Perhaps they could have like a pre questionnaire, what does your daily routine involve 461 
today and then a follow up, what does your routine do today and compare them.” (PFG07 462 
carer) 463 
“rather than it being an actual symptom that may get better or get worse, it’s their 464 
confidence in managing their symptoms …a lot of it will be around them just feeling that 465 
they’ve got the skills, they’re equipped to manage on their own.” (CFG02 AHP) 466 
Intervention process  467 
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All participants recommended measuring the nature and number of rehabilitation 468 
components, the frequency, mode and location of contacts, as well as experience and 469 
satisfaction with rehabilitation. 470 
 471 
“I would think that, probably the group that felt it was not doing them any good would tend 472 
to start staying away.” (PFG05 patient) 473 
 474 
Oncology treatment related  475 
In addition to the number of participants joining and completing the trial, clinicians 476 
recommended assessing whether oncology treatments were received as planned, reasons for 477 
discontinuing treatment, treatment toxicity scores, unplanned hospital admissions and use of 478 
other health care services during the trial period.  479 
 480 
They might have, I think, better tolerance for the treatment as well. I think they can tolerate 481 
better if they're well supported psychologically and so on. Those kind of things we include, 482 
the hospital stay, for example, what is their outcome and whether we had to reduce the dose 483 
of chemotherapy and so on, all those things we can do. (CFG11 oncologist) 484 
 “I don’t know if there are any independence scores that assess how independent patients 485 
stay, and compare that with the toxicity profile that we get from the chemotherapy, so you 486 
can see that patients react differently to the chemotherapy?” (CFG12 oncologist) 487 
Discussion 488 
We conducted focus groups to develop and refine a complex intervention and procedures for 489 
a future randomised feasibility trial. The findings have illuminated factors to be refined in the 490 
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conduct of a planned trial in this population. Implications include an improved understanding 491 
of contextual factors and mechanisms of action relating to intervention components, specific 492 
trial processes, and the selection of feasibility and clinical outcomes. The findings redirect the 493 
focus of the rehabilitation model towards helping people stay active and independent as they 494 
commence treatment by addressing beliefs, symptoms and psychological concerns that limit 495 
participation in daily life. Intervention components should include strategies to address needs 496 
in patients across the age range and with varying performance status. Recognising that people 497 
are often overwhelmed at diagnosis, information given should be individualised and brief, 498 
with strategies focused on immediate needs. The service should work towards meaningful 499 
goals, including improved capacity to tolerate oncology treatments. For people who feel well 500 
and have higher levels of fitness, a positive training approach should support people maintain 501 
independence and get the most from planned oncology treatments. This pro-active approach 502 
should seek to improve participants’ self-confidence to cope and address illness 503 
understandings, belief and fears that impact on function. It should support ongoing 504 
participation in usual activities and reduce sedentary time to maintain independence and 505 
fitness. This study confirms findings from previous research that patients place importance 506 
on how interventions are delivered.[37] Encouraging and supporting usual habitual activities 507 
wherever possible should align with patients desires to keep life normal, to not feel 508 
ill. Tailored exercise strategies can be added for those who are motivated. Strategies to 509 
manage common symptoms should be offered to all patients. This should provide immediate 510 
relief for those experiencing symptoms and include preventive and proactive strategies for 511 
those at risk of developing them during or following treatment. Previous rehabilitation 512 
studies in this population group have focused on discrete interventions, such as 513 
breathlessness management or exercise to address impairments.[11] However, beliefs 514 
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pertaining to potential harm may preclude participation in rehabilitation, including 515 
exercise.[9, 12, 13] If symptoms are not present, people may see no value in participating in 516 
symptom self-management.[10, 38]  517 
Our findings corroborate findings of previous qualitative studies. The intervention and the 518 
trial processes should be flexible, integrating with usual oncology services to reduce the 519 
barriers that arise when patients are required to attend additional hospital appointments.[9, 520 
10]  Home-based appointments may improve recruitment and retention. Our trial eligibility 521 
criteria were refined because of the focus groups. The trial should recruit patients on any 522 
treatment pathway to maximise recruitment but also provide equitable care. The importance 523 
placed on the interpersonal attributes of the researchers have implications for all members 524 
of a feasibility trial research team. Those involved in screening should approach potential 525 
participants with sensitively, with an understanding of their unique context. Information 526 
about the trial can be paced during the screening and informed consent process, using a one-527 
sided summary flyer, followed by the full participant information leaflet for those requesting 528 
further information.  529 
Clinical outcomes should focus on domains meaningful to the varying needs of patients.  530 
Process outcomes should include treatment completion rates, important to clinicians and 531 
patients. Although challenging, our findings suggest that delivering interventions following 532 
diagnosis, is warranted[39-41]  and we, like others,[42] suggest that integrating into existing 533 
services and modelling services with close involvement of all involved will facilitate future 534 
practice change. 535 
Our initial development work for the trial intervention was underpinned by models and 536 
theories of rehabilitation[16] and behaviour change (The Behaviour Change Wheel,[17] 537 
Intervention Mapping[18] and Implementation Intention Planning.[19]) However, our 538 
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findings suggest that these theories alone may not have the best ‘ecological fit’[35] in the 539 
context of a new diagnosis of thoracic cancer. Importantly, these theories may not illuminate 540 
potential mechanisms of action relating to the sudden change in circumstances or 541 
uncertainties experienced by patients and their families. As a result the intervention likely has 542 
a reduced scope of action.  543 
Theories of illness provide explanations for contextual factors such as the tensions 544 
experienced by patients who want to remain well and continue with normal life yet struggle 545 
to prioritise rehabilitation. Reorientation of self-identity and adjustment takes effort and 546 
time, varying depending on the context of each person and the approach taken by the 547 
clinicians providing their care.[43-45] The manner of approach and the focus of rehabilitation 548 
contacts should be context sensitive and tailored, addressing all possible mechanisms of 549 
action, including those relating to experiences of illness. These will include the 550 
‘immediacy’[44] of participants’ current life experience, their pressing needs, concerns and 551 
beliefs following diagnosis. Use of illness theory will support refinement of the rehabilitation 552 
model so these factors are addressed in the intervention design, implementation and 553 
evaluation.  554 
 555 
Strengths and limitations 556 
The focus group study has refined the underpinning theory, design and implementation 557 
processes of a rehabilitation model for testing in a future feasibility trial.[46]  Participants 558 
were recruited from all proposed trial sites and clinical groups who will be referring patients 559 
to the trial. We recruited patients (with diagnoses of both lung cancer and mesothelioma) 560 
and informal carers with a diversity of ages and life situation. The interaction between 561 
participants generated rich data concerning the variation in performance status, impairments 562 
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and functional expectations present in this population. One limitation in our sampling is the 563 
possibility that only fitter patients interested in rehabilitation were recruited. They may not 564 
represent views of people who are more unwell. However, participants reported experiences 565 
of patients with lower levels of fitness and motivation and this has influenced our planned 566 
screening strategies and the intervention components. Challenges were experienced getting 567 
participants to focus groups on the same day resulting in two patient focus groups of three 568 
participants and one with two, which potentially limited participant interaction.[28] However, 569 
in these cases participants engaged with each other and revealed unique perspectives not 570 
discussed in larger focus groups. Again these contributed to the development of the themes 571 
during analysis. The action orientated pragmatic nature of this study meant we did not 572 
analyse latent themes[32] or consider wider structural issues which may impact on the 573 
implementation and outcomes of the intervention.[47] However, the findings have 574 
broadened our theoretical perspective and improved our rehabilitation model to improve the 575 
quality and evaluation of the planned randomised feasibility trial (ISRCTN92666109). 576 
 577 
Conclusion  578 
The focus group findings provide insights for the development of rehabilitation interventions 579 
in patients with lung cancer and mesothelioma, which were used to refine the intervention 580 
content and delivery, working processes, and target outcomes for a future feasibility trial. The 581 
rehabilitation intervention builds on the findings of earlier studies and is modelled using 582 
patient, carer and clinician views around delivery. It is inclusive, addresses a range of 583 
functional limitations and aims to integrate with oncology services. Beyond these direct 584 
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implications, our findings can help inform the development of pro-active rehabilitation 585 
interventions in other populations newly diagnosed with advanced disease. 586 
 587 
Figure 1 Outline rehabilitation logic model.[14] 588 
Figure 2 Refined rehabilitation logic model.[14] 589 
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 732 
Appendix 1. Focus Group Topic Guide 733 
1) Thinking about the people in the stories & your own experiences 734 
can you tell us what day to day life is like for people in that time after they’ve been 735 
diagnosed? 736 
i) What might help people to manage, to stay active & independent? 737 
ii) How would people feel being given information about practical things they can 738 
do now to help with their current symptoms and concerns? 739 
iii) How would people feel discussing things they can do now to prevent symptoms, 740 
like weakness & breathlessness, developing in the future? 741 
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The proposed rehab service: 742 
1 to 3 appointments for patient & significant other with a physiotherapist or 743 
occupational therapist focusing on symptom management and physical activity to 744 
optimise function and participation in daily activities and roles. 745 
2) Can you tell us your thoughts about how people might feel if offered this service?  746 
i. How would it fit in with medical treatments and clinic appointments?  747 
ii. How might it help? 748 
iii. Does this kind of a service have a place in cancer care? 749 
iv. Can you foresee any problems, for instance what about after the service? 750 
 751 
3) What do we need to think about when we are inviting people to join the research study?  752 
i. What might influence whether people join the study? 753 
ii. We’ll ask people to complete questionnaires before and after the service. What 754 
kind of questions will help us find out if the service has been helpful or not?  755 
How long should the questionnaire be? 756 
iii. Is there anything you’d like to add about the new rehabilitation service or the 757 
research study that we haven’t covered?  758 
 759 
 760 
